Aptamers Explained: DNA Biosensors for Neuropeptide Detection

Neuropeptides are signaling molecules secreted by neurons that act as neurotransmitters or neuromodulators to transmit messages within the brain and nervous systems, involved in pain sensation, stress responses, feeding behavior, and reproduction. The term 'neuropeptide' is somewhat of a misnomer because these peptides can also be made and sensed by non-neuronal tissue, making them more accurately described as bioactive peptides. Neuropeptide signaling differs fundamentally from classical neurotransmission at synapses, operating on slower timescales (seconds to hours) and signaling over long distances between cells that are not physically connected. Neuropeptide signaling systems are highly complex with multiple regulatory components including the signal, receptors, and enzymes (peptidases) that shape timing and anatomical paths of signaling. The diversity of neuropeptide signaling systems across species is remarkable, with humans and worms having similar numbers of neuropeptides and receptors, suggesting this signaling system evolved early and has been maintained throughout evolution.

Neuropeptides are a special class of signal molecules in the nervous system. Unlike classical neurotransmitters, which are usually small molecules acting quickly and locally, neuropeptides are larger chains of amino acids that often act more slowly and over longer distances. They are made in the cell body of the neuron and transported down the axon to vesicles in the synapse. Instead of simply turning the next neuron on or off, neuropeptides modulate neural activity, meaning they fine-tune the strength, duration, or sensitivity of signals, often working alongside traditional neurotransmitters to shape how the nervous system responds. For example, they can make excitatory signals stronger, inhibitory signals more effective, or adjust how responsive a neuron is to repeated stimulation. Because of this modulatory role, neuropeptides are involved in complex and lasting processes like pain perception, stress responses, appetite, sleep, mood, and learning. Well-known neuropeptides include substance P (transmits pain signals in the spinal cord and brain) and the body's natural opioids (endorphins and enkephalins, which reduce pain and produce feelings of euphoria).

Neuropeptides represent the most biochemically complex group of chemical signals in the nervous system. Even in C. elegans, which has only 302 neurons, there are hundreds of different individual neuropeptides, each binding to specific receptors. There are approximately 150 different neuropeptide binding receptors even in this small nervous system. These neuropeptide signaling networks function as 'wireless' communication systems that allow neurons not directly connected by synapses to communicate with each other. This form of communication is distinct from classical synaptic transmission and represents a fundamental mechanism for modulating brain activity and behavior.

The nervous system contains numerous neuropeptides that serve as neuromodulators with diverse physiological functions. Oxytocin and vasopressin are involved in social bonding, stress response, and regulation of water balance and blood pressure. Growth hormone releasing hormone (GHRH) stimulates growth hormone release from the pituitary gland, promoting growth and metabolic processes. Somatostatin inhibits the release of growth hormone and other hormones. Endorphins and enkephalins are endogenous opioid peptides that bind to opioid receptors to produce analgesic effects. Neuropeptide Y is involved in appetite regulation, stress response, and cardiovascular function. These neuropeptides are distributed throughout the nervous system and modulate various physiological processes including pain perception, appetite, stress response, and endocrine function.

Neuropeptides are small protein-like chemical messengers that function as neurons. They are part of the nervous system's chemical language and play a major role in how we think, feel, and respond. They regulate emotions, pain, stress responses, immune function, hormone release, social bonding, learning, and memory. There are over 100 known neuropeptides in the human body.

A Field Effect Transistor (FET) consists of three terminals: Drain, Gate, and Source. The Source supplies majority charge carriers (electrons in N-channel, holes in P-channel) to the channel, while the Drain collects them. Charge carriers flow from Source to Drain through the channel, creating Drain-to-Source current (ID for N-channel, IS for P-channel). FETs are voltage-controlled devices where the Gate terminal applies voltage to create an electric field that controls channel conductivity. N-channel FETs are preferred over P-channel because electrons have higher mobility than holes. The Gate voltage controls the channel width and conductivity without requiring significant current flow into the Gate, making FETs more efficient than current-controlled BJTs.

A Field Effect Transistor (FET) is a phenomenon where the conductivity of a semiconductor is modulated by an electric field applied normal to the semiconductor surface. The electric field affects how easily charge carriers can move through the semiconductor material, thereby changing its conductive properties without requiring additional doping of the semiconductor material.

A field effect transistor (FET) is a semiconductor device where resistivity between source and drain terminals is controlled by a third gate terminal. Without gate voltage, the p-doped semiconductor structure blocks current flow like a blocked pn junction. When positive gate voltage is applied, electrons accumulate at the semiconductor-insulator interface, forming an inversion channel that erases the junction barriers and enables current flow. The simple theory relates conductivity to carrier density via Ohm's law, with carrier density controlled by gate voltage through a capacitance relationship. This creates a linear gate-voltage dependence of conductivity, forming the basis of FET operation as a voltage-controlled switch.

The FET operates based on the gate voltage applied to control current flow between drain and source. When a positive voltage is applied to the gate of an N-channel FET, it attracts positive charges toward the channel, which in turn attracts negative charges from the N-type crystal, allowing current to flow from drain to source. Conversely, a negative gate voltage attracts positive charges to the gate and repels negative charges, preventing current from flowing through the channel. This creates an electric field that controls conductivity.

Field Effect Transistors (FETs) revolutionized electronics in the 1970s-1980s, enabling calculators, computers, and modern electronic devices. Theoretical work by Julius von Lilienthal in 1930 led to Bell Labs' development, with William Shockley patenting the FET in 1951 and the first successful fabrication in 1952. FETs are unipolar devices that use electric fields to control single-type charge carrier channels. The electric field is defined as a force field created by charge attraction and repulsion, always drawn from positive to negative charges. FETs exploit this principle to generate conduction channels when sufficient voltage creates strong enough attraction forces between particles.

Biosensors are integrated receptor-transducer devices that provide selective analytical information using biological recognition elements. Unlike physical sensors like thermometers, biosensors specifically detect biological species through molecular recognition. The three essential components are: (1) biological recognition element for target analyte interaction, (2) transducer converting recognition events to measurable signals, and (3) readout system. Recognition elements require selectivity, stability, and strong binding affinity. Common interactions include DNA hybridization, receptor-ligand binding, antibody-antigen recognition, and enzyme-substrate reactions.

Biosensors consist of two main components: (1) Receptor - the biological component that recognizes the target analyte (such as enzymes, antibodies, or microorganisms); (2) Transducer - converts the biological changes into electrical signals. Semiconductors or electrodes can be used as transducers. The three steps involved in biosensor operation are: (1) Biological recognition takes place; (2) The transducer converts the biological change from one form of energy to another; (3) The result is amplified and useful information is displayed.

This section details how biosensors function as analytical devices converting biological responses into quantifiable signals. The core architecture consists of two interconnected components: a recognition element (receptor) and a transducer. Recognition elements include nucleic acids, antibodies, cells, and enzymes, each offering unique specificity for target analytes. The working principle involves: (1) bio-receptor binding to analytes, (2) biological events at interfaces, (3) signal pickup by transducers, (4) electrical signal conversion, (5) amplification by detector circuits, and (6) computer-based data processing. Two sensing mechanisms are distinguished: direct sensing where targets bind directly to electrode ligands, and indirect sensing where ambient reactions produce detectable products. These principles underpin all subsequent discussions of magnetic biosensor design and application.

A biosensor consists of two main components: a biorecognition element and a transducer. The biorecognition element specifically interacts with the target analyte (such as glucose, DNA, or virus particles), while the transducer converts this interaction into an electronic signal. Biosensors can be classified by their biorecognition elements: enzymatic biosensors use enzymes, immunosensors use antibodies or antigens, DNA sensors use single-stranded DNA, aptasensors use artificial antibodies called aptamers, cell sensors use whole cells, microbial sensors use bacteria or algae, and molecular imprint polymer sensors use synthetic polymers shaped to recognize specific molecules.

A biosensor consists of three main components: (1) The analyte to be detected; (2) A biological recognition element (enzyme, antibody, nucleic acid, or whole cell) that specifically binds to the analyte; (3) A transducer that converts the biological recognition event into a measurable signal. The transducer can be electrochemical, optical, thermal, or piezoelectric. The signal is then processed by connected equipment, which can include portable devices that read signals directly or connect via Bluetooth to smartphones or displays.